Update as of 14 May 2025 : Since the public consultation and appeals period for the HTA Council Preliminary Recommendation on Ceftaroline Fosamil (600 mg powder for concentrate for solution for injection) in the Treatment of Community-Acquired Pneumonia (CAP) in Children ended on 13 May 2025 without any appeals received, this preliminary HTA Council recommendation lapsed into the Final continue reading : HTA Council Preliminary Recommendation on Ceftaroline Fosamil (600 mg powder for concentrate for solution for injection) in the Treatment of Community-Acquired Pneumonia (CAP) in Children
HTA Council Preliminary Recommendation on Coagulation Factor VIII and Factor VIII Inhibitor Bypassing Activity
Update as of 29 April 2025 : Since the public consultation and appeals period for the HTA Council Preliminary Recommendation on Coagulation Factor VIII and Factor VIII Inhibitor Bypassing Activity ended on 25 April 2025 without any appeals received, this preliminary HTA Council recommendation lapsed into the Final Recommendation and was transmitted to the Secretary of Health on 29 April continue reading : HTA Council Preliminary Recommendation on Coagulation Factor VIII and Factor VIII Inhibitor Bypassing Activity
HTA Council Preliminary Recommendation on Hexavalent Vaccine for active immunization of infants to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis b, and invasive disease due to Haemophilus influenzae type b
As of 05 March 2025, the Health Technology Assessment (HTA) Council makes public its preliminary recommendation on the non-inclusion in the PNF and thus the non-government financing of hexavalent vaccine, for stakeholder feedback/comments. Overall, the HTA Council recognizes that hexavalent vaccines will result in a simpler immunization schedule and thus, better compliance and easier implementation. continue reading : HTA Council Preliminary Recommendation on Hexavalent Vaccine for active immunization of infants to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis b, and invasive disease due to Haemophilus influenzae type b
HTA Council Preliminary Recommendation on Fecal Immunohistochemical Test (FIT) for colorectal cancer in apparently healthy adults aged 50 years and above
Update as of 19 March 2025 : Since the public consultation and appeals period for the HTA Council Preliminary Recommendation on Fecal Immunohistochemical Test (FIT) for colorectal cancer in apparently healthy adults aged 50 years and above ended on 12 March 2024 without any appeals received, this preliminary HTA Council recommendation lapsed into the Final Recommendation and was transmitted to continue reading : HTA Council Preliminary Recommendation on Fecal Immunohistochemical Test (FIT) for colorectal cancer in apparently healthy adults aged 50 years and above
HTA Council Preliminary Recommendation on High-risk Human Papillomavirus (HPV) DNA Test and Visual Inspection with Acetic Acid
Update as of 13 March 2025: The public consultation and appeals period for the HTA Council’s Preliminary Recommendation on the (1) High-Risk Human Papillomavirus (HrHPV) DNA Test and (2) Visual Inspection with Acetic Acid (VIA) for cervical cancer screening in women aged 30–65 years ended on 25 February 2025. HTA Philippines received and processed one continue reading : HTA Council Preliminary Recommendation on High-risk Human Papillomavirus (HPV) DNA Test and Visual Inspection with Acetic Acid